Clinical Trial Update: Crohn's Disease: Efficacy, Safety, and Pharmacokinetics of Upadacitinib in Pediatric Subjects With Moderately to Severely Active Crohn's Disease [Phase 3]

View source ↗

Summary

A Phase 3 pediatric trial is evaluating the efficacy, safety, and pharmacokinetics of Upadacitinib in moderately to severely active Crohn's disease, and the stu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease

Drugs mentioned

• Upadacitinib (upadacitinib)

Snippet

Sponsor: AbbVie | Conditions: Crohn's Disease | Phase 3 | Status: RECRUITING